Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,630 | 61,385 | 90,285 | 71,625 | 103,147 |
| Receivables | 158,429 | 137,673 | 109,726 | 99,412 | 49,999 |
| Inventories | 206,465 | 196,667 | 191,464 | 172,188 | 170,235 |
| Other current assets | 6,530 | 0 | 0 | 0 | 0 |
| TOTAL | $466,512 | $402,655 | $399,563 | $351,814 | $331,410 |
| Non-Current Assets | |||||
| PPE Net | 65,057 | 69,509 | 57,501 | 57,710 | 54,707 |
| Intangibles | 4,162 | 4,021 | 4,057 | 3,982 | 3,990 |
| Other Non-Current Assets | 88,511 | 92,502 | 97,259 | 97,063 | 98,571 |
| TOTAL | $157,730 | $166,032 | $158,817 | $158,755 | $157,268 |
| Total Assets | $624,242 | $568,687 | $558,380 | $510,569 | $488,678 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,519 | 24,021 | 29,769 | 20,607 | 20,219 |
| Accrued Expenses | 40,466 | 28,827 | 43,902 | 31,560 | 34,105 |
| Other current liabilities | 2,647 | N/A | N/A | N/A | N/A |
| TOTAL | $69,541 | $56,490 | $74,941 | $53,498 | $55,542 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,330 | 70,084 | 73,397 | 72,527 | 72,337 |
| Deferred Revenues | N/A | N/A | 143 | 143 | N/A |
| Other Non-Current Liabilities | 0 | 90 | 940 | 1,315 | 1,673 |
| TOTAL | $77,381 | $81,011 | $85,114 | $83,652 | $84,118 |
| Total Liabilities | $146,922 | $137,501 | $160,055 | $137,150 | $139,660 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 238,159 | 237,998 | 238,631 | 238,734 | 237,615 |
| Common Shares | 24 | 24 | 24 | 24 | 24 |
| Retained earnings | -161,653 | -211,032 | -247,460 | -281,679 | -308,583 |
| Other shareholders' equity | -90 | -188 | -148 | 0 | 0 |
| TOTAL | $477,320 | $431,186 | $398,325 | $373,419 | $349,018 |
| Total Liabilities And Equity | $624,242 | $568,687 | $558,380 | $510,569 | $488,678 |